Nifty Healthcare Index
NIFTY HEALTHCARENifty Healthcare Index
NIFTY HEALTHCARE
Price Chart
Key Metrics
| PE RatioPE Ratio | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 42.53 | 6.46 | 0.58% |
| Market Cap ShareM Cap Share | ConstituentsConstituents | ETFsETFs |
|---|---|---|
| 3.83% | 20 | — |
About Index
Nifty Healthcare Index is designed to reflect the behaviour and performance of the Healthcare companies. The Nifty Healthcare Index comprises of maximum of 20 tradable, exchange listed companies.
Get more out of Tickertape, Go Pro!
Unlock exclusive stocks’ data & unlimited access with Tickertape Pro
Free float marketcap values in ₹ thousand cr.
| Stocks | 1D change | Return attribution | Index weight | Free float marketcap | |
|---|---|---|---|---|---|
| NIFTY HEALTHCARE 1D return-0.08% | 0.08% | -0.08% | 100.00% | Free float Mcap871.15 Weight100.00% | |
Abbott India LtdABBOTINDIA 0.35% Return attribution-0.01% | 0.35% | -0.01% | 1.71% | 14.90 Weight1.71% | |
Alkem Laboratories LtdALKEM 1.15% Return attribution-0.03% | 1.15% | -0.03% | 2.37% | 20.68 Weight2.37% | |
Apollo Hospitals Enterprise LtdAPOLLOHOSP 0.45% Return attribution0.04% | 0.45% | 0.04% | 8.30% | 72.30 Weight8.30% | |
Aurobindo Pharma LtdAUROPHARMA 0.51% Return attribution-0.02% | 0.51% | -0.02% | 3.64% | 31.70 Weight3.64% | |
Biocon LtdBIOCON 1.09% Return attribution-0.02% | 1.09% | -0.02% | 1.81% | 15.81 Weight1.81% | |
Zydus Lifesciences LtdZYDUSLIFE 0.20% Return attribution0.01% | 0.20% | 0.01% | 2.81% | 24.47 Weight2.81% | |
Cipla LtdCIPLA 0.13% Return attribution0.01% | 0.13% | 0.01% | 8.81% | 76.78 Weight8.81% | |
Dr Reddy's Laboratories LtdDRREDDY 0.08% Return attribution0.01% | 0.08% | 0.01% | 8.40% | 73.16 Weight8.40% | |
Divi's Laboratories LtdDIVISLAB 1.26% Return attribution-0.11% | 1.26% | -0.11% | 8.57% | 74.62 Weight8.57% | |
Glenmark Pharmaceuticals LtdGLENMARK 1.10% Return attribution-0.03% | 1.10% | -0.03% | 2.43% | 21.16 Weight2.43% | |
Granules India LtdGRANULES 0.76% Return attribution-0.01% | 0.76% | -0.01% | 0.92% | 8.00 Weight0.92% | |
IPCA Laboratories LtdIPCALAB 1.69% Return attribution-0.04% | 1.69% | -0.04% | 2.34% | 20.39 Weight2.34% | |
Dr. Lal PathLabs LtdLALPATHLAB 1.23% Return attribution-0.02% | 1.23% | -0.02% | 1.27% | 11.09 Weight1.27% | |
Laurus Labs LtdLAURUSLABS 1.71% Return attribution0.04% | 1.71% | 0.04% | 2.35% | 20.44 Weight2.35% | |
Lupin LtdLUPIN 2.03% Return attribution-0.12% | 2.03% | -0.12% | 5.75% | 50.10 Weight5.75% | |
Max Healthcare Institute LtdMAXHEALTH 1.06% Return attribution0.11% | 1.06% | 0.11% | 10.04% | 87.48 Weight10.04% | |
Metropolis Healthcare LtdMETROPOLIS 0.11% Return attribution-0.00% | 0.11% | -0.00% | 0.66% | 5.77 Weight0.66% | |
Sun Pharmaceutical Industries LtdSUNPHARMA 0.44% Return attribution0.10% | 0.44% | 0.10% | 22.13% | 192.78 Weight22.13% | |
Syngene International LtdSYNGENE 0.24% Return attribution-0.00% | 0.24% | -0.00% | 1.79% | 15.59 Weight1.79% | |
Torrent Pharmaceuticals LtdTORNTPHARM 0.54% Return attribution0.02% | 0.54% | 0.02% | 3.90% | 33.95 Weight3.90% |
ETFs tracking this Index
There are no ETFs tracking this index. Events
Dividends
Corp. Actions
Announcements
What are dividends?
Dividends are a portion of earnings that a company distributes to all its shareholders every year. Dividend return is one of the most important things to be considered while investing for long term. It’s the additional return on top of what investors earn through price appreciation
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash DividendIPCALAB
IPCALABEx DateEx DateNov 27, 2024
Dividend/Share
₹2.00
Ex DateEx Date
Nov 27, 2024
Cash DividendLAURUSLABS
LAURUSLABSEx DateEx DateNov 6, 2024
Dividend/Share
₹0.40
Ex DateEx Date
Nov 6, 2024
Cash DividendLALPATHLAB
LALPATHLABEx DateEx DateNov 5, 2024
Dividend/Share
₹6.00
Ex DateEx Date
Nov 5, 2024
Cash DividendGLENMARK
GLENMARKEx DateEx DateSep 13, 2024
Dividend/Share
₹2.50
Ex DateEx Date
Sep 13, 2024
Cash DividendMAXHEALTH
MAXHEALTHEx DateEx DateAug 23, 2024
Dividend/Share
₹1.50
Ex DateEx Date
Aug 23, 2024
News & Opinions
Hmm, looks like data is unavailable here. Please come back after some time.
